A multicenter, open-label long-term safety study of rimegepant for the acute treatment of migraine

  • Robert Croop
  • , Gary Berman
  • , David Kudrow
  • , Kathleen Mullin
  • , Alexandra Thiry
  • , Meghan Lovegren
  • , Gilbert L’Italien
  • , Richard B. Lipton

Research output: Contribution to journal › Article › peer-review

29 Scopus citations

Fingerprint

Dive into the research topics of 'A multicenter, open-label long-term safety study of rimegepant for the acute treatment of migraine'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Keyphrases